Helomics Corporation

91 43RD St Ste 110
Pittsburgh, PA, 15201-3161  United States
(412) 432-1500
Company Type: Corporation Subsidiary

Helomics knows that chemotherapy isn't "one size fits all." That's why the company developed and markets ChemoFx, a product that examines the response of a specific patient's tumor to various chemotherapies. Physicians can use the test to collect cells from a solid tumor, then Helomics performs tissue cultures and tries various chemotherapeutic and biologic agents to measure the best type, combination, and dose of chemotherapy to help combat the disease in individual patients. The company has been studying ChemoFx use with ovarian and breast tumors, among others. The company markets its products and services through a direct sales force. Helomics is a subsidiary of Precision Therapeutics.

Try D&B Hoovers Free

Competitor Profiles

See detailed profiles for insights and prospects on this company's top competitors.

For Your Call

Essential information for a successful call

  •  SALES (MIL USD) 0.99
  • Incorporated 2019
  • CREDIT PRESCREEN HIGH RISK

Get in Touch with 3 Contacts

A D&B Hoovers Subscription is your foot in the door to Helomics Corporation contact information.
  • Nicholas Reitze
    Director, Laboratory Operations
  • Bruce Robin
    Senior Director of Program Management
  • Mary Scullion
    Infrastructure Systems Manager
See full contact details
Start Your Free Trial

Get full access to D&B Hoovers

With a Hoovers subscription you can get a comprehensive view of Helomics Corporation

Helomics Corporation

3
Contacts
Reach the right people with access to detailed contact information.
3
Corporate Relations
Get the big picture on a company's affiliates and who they do business with.
9
Close Industry Peers
See similar companies for insight and prospecting.